Introduction {#Sec1}
============

According to a consensus statement of the Scoliosis Research Society,^[@CR1]^ any spinal deformity occurring before the age of ten years is referred to as early onset scoliosis (EOS), regardless of the aetiology. Despite ongoing technical development and increasing knowledge about deformity evolution, the treatment of EOS remains challenging. Based on the understanding of the dependence of spinal and thoracic growth and lung development with devastating consequences in case of early operative spinal fusion, various growth-friendly techniques have been developed.^[@CR2]^ The expanding variety of operative techniques led to a neglect of conservative treatment options, but the surgical enthusiasm subsided with numerous reports of considerable surgery-related complications leading to a renaissance of nonoperative treatment methods. Serial Mehta or Risser casting represent conservative techniques to sometimes treat patients with EOS or at least delay surgery.^[@CR3]-[@CR5]^

In cases of progressive EOS with coronal plane deformities exceeding 50° to 60°, operative strategies may nevertheless become necessary.^[@CR6],[@CR7]^ Distraction-based systems have been favoured to control the deformity and stimulate growth of the spine and thorax, aiming for as normal pulmonary function as possible. In the case of absence of rib anomalies and thoracic insufficiency syndrome there is consensus to use (dual) growing rods.^[@CR8]^ The development of motorized implants lowered the heavy psycho-social burden of repetitive surgical implant lengthening under general anaesthesia, and the complication rate appears to be less. First reports on early follow-up with magnetically controlled growing rods (MCGR) are promising but, as with any medical achievement, this new technique must stand the test of time.^[@CR9]-[@CR11]^ Recent reports have pointed to problems that can only be objectively determined through continuous evaluation and documentation and the establishment of central registries.^[@CR12]-[@CR14]^

We would like to report on the radiographic parameters and complications experienced in our first 30 patients who underwent MCGR implantation and compare our findings with the existing literature. We also describe a fixation technique that enables the use of MCGR even in very young children with a small bony anatomy. In addition, we address challenges and problems in patients who underwent conversion to MCGR from previous non-motorized growth-sparing surgical treatment.

Patients and methods {#Sec2}
====================

After getting written informed consent from the patients and their families/care givers, and with the approval of the institutional review board, the medical records of patients having had implantation of MCGRs (MAGEC System; NuVasive, San Diego, California) were screened for demographics, aetiology of the EOS according to the C-EOS-classification system,^[@CR15]^ previous treatment, as well as complications and unplanned returns to the operating room (OR). Complications were considered for all 30 patients, regardless of follow-up time. The severity of the complications was classified as proposed by Smith et al.^[@CR16]^ Existing imaging was analyzed for changes in major curve (Cobb's angle) and main kyphosis before and after MCGR insertion, as well as at latest follow-up for patients with a minimum follow-up of two years after MCGR implantation (n = 18). Furthermore, changes in T1 to T12 and T1 to S1 distances were documented. T1 to T12 and T1 to S1 distances were defined as the length of a straight line on an anteroposterior (AP) whole spine radiograph connecting the midpoint of the upper endplate of T1 to the midpoint of the lower endplate of T12, or the midpoint of the upper endplate of S1, respectively. In addition, kind and levels of fixation were documented. Separate analyses were carried out for patients who were previously treated with non-motorized growth-sparing implants.

According to our treatment protocol, outpatient MCGR extensions take place every three months. At each consultation the amount of implant lengthening is objectified and documented by ultrasound, and every six months an AP and lateral whole spine radiograph prior to implant extension is performed to check the correct implant position and to document the evolution of the deformity. Until April 2017, the radiograph controls were carried out with a digital radiograph machine (Intuition; Leuag AG, Alpnach Dorf, Obwalden, Switzerland) and from May 2017 this was done with the EOS imaging system (EOS Imaging; EOS Imaging SA, Paris, France). The change of the radiograph unit had to be taken into account when evaluating the changes in the T1 to T12 and T1 to S1 distances, since the ray divergence of the digital radiograph (Intuition) system initially used results in a magnification of the image, which is not the case with the EOS Imaging system that relies on a linear ray pattern.

Statistical analysis
--------------------

The major curve, main kyphosis and the T1 to S1 length were evaluated at each time point of the procedure; preoperatively, immediately postoperatively and after several implant elongations at three months (one elongation), nine months (three elongations), 18 months (five elongations), 21 months (seven elongations) and at 27 months (nine elongations). Paired *t*-tests were performed to compare the change in angle or length between subsequent timepoints. Paired *t*-tests were also used to compare the preoperative situation with the situation after nine elongations. Comparisons were performed for all the patients as well as for two subgroups; patients who underwent conversion from non-motorized growth-sparing implants and patients who received MCGR as primary surgical treatment.

Results {#Sec3}
=======

Between April 2015 and March 2018, 30 patients (20 female, ten male) underwent MCGR implantation at our institution. All patients and/or their families/care givers agreed to be enrolled in the study. Demographic data, aetiology of the EOS, previous treatment and kind and level of fixation are summarized in [Table 1](#Tab1){ref-type="table"}. Mean age at the time of MCGR implantation was 9.4 ([sd]{.smallcaps} 3.5; 1.8 to 18.4). In all, 12 patients were older than ten years at the time of MCGR insertion. In ten of these 12 patients the Risser stage^[@CR17]^ was still 0. The oldest patient was 18.4 years at index surgery with a congenital EOS due to a vertebral defect, anal atresia, cardiac defects, tracheo-esophageal fistula, renal anomalies and limb abnormalities (VACTERL) syndrome. Despite being Risser stage 4, his bone age determined with the BoneXpert software (BoneXpert, Visiana, Horsholm, Denmark) was four years retarded and his body height was only 147 cm. In addition, a tethered cord was present on MRI, requiring neurosurgical intervention. Respecting these factors and according to the patient's wish, the decision to delay final fusion surgery and to use MCGR was made. Another female patient with idiopathic EOS, Risser stage 2 and a body height of 150 cm had MCGR insertion at 14.9 years of age.

###### 

Overview of demographic, health-related and technical data of patients undergoing treatment with magnetically controlled growing rods (MCGRs)

  ID       Gender   C-EOS           Previous treatment   Age (yrs) at MCGR implantation   Risser at MCGR implantation   Mono/bilateral MCGR   MAGEC system    Proximal foundation   Distal foundation    Additional surgical procedures
  -------- -------- --------------- -------------------- -------------------------------- ----------------------------- --------------------- --------------- --------------------- -------------------- ------------------------------------------------------------------------------
  MCGR01   Female   Neuromuscular   Brace                7.4                              0                             Bilateral             4.5 mm, 90 mm   Hooks T4 to T6        Screws L4 to L5      
  MCGR02   Male     Syndromic       Cast                 4.1                              0                             Bilateral             4.5 mm, 70 mm   Hooks T1 to T3        Screws L3 to L4      
  MCGR03   Female   Neuromuscular   VEPTR                6.6                              0                             Monolateral           5.5 mm, 70 mm   VEPTR rib cradle      Screws T12 to L1     
  MCGR04   Female   Syndromic       VEPTR                12.7                             0                             Bilateral             5.5 mm, 90 mm   VEPTR rib cradles     VEPTR Ala hooks      
  MCGR05   Male     Congenital      VEPTR                9.8                              0                             Monolateral           5.5 mm, 70 mm   VEPTR rib cradle      Screws L2 to L3      
  MCGR06   Female   Idiopathic      Brace                10.0                             0                             Bilateral             5.5 mm, 90 mm   Hooks T2 to T4        Screws L3 to L4      
  MCGR07   Female   Idiopathic      Brace                12.6                             0                             Bilateral             5.5 mm, 90 mm   Hooks T2 to T4        Screws L1 to L2      
  MCGR08   Male     Congenital      VEPTR                9.8                              0                             Bilateral             6.0 mm, 90 mm   VEPTR rib cradles     VEPTR Ala hooks      
  MCGR09   Female   Neuromuscular   Brace                7.5                              0                             Monolateral           4.5 mm, 70 mm   Hooks T3 to T5        Screws L3 to L5      
  MCGR10   Female   Neuromuscular   Brace                10.6                             0                             Bilateral             5.5 mm, 90 mm   Hooks T2 to T4        Screws L3 to L5      
  MCGR11   Male     Congenital      None                 7.3                              0                             Bilateral             4.5 mm, 70 mm   Screws T2 to T3       Screws T12 to L1     
  MCGR12   Male     Congenital      VEPTR                10.5                             0                             Monolateral           6.0 mm, 70 mm   VEPTR rib cradle      Screws T12 to L1     
  MCGR13   Female   Congenital      VEPTR                8.6                              0                             Monolateral           6.0 mm, 70 mm   VEPTR rib cradle      Screws T12 to L1     Apical convex pedicle screw epiphyseodesis
  MCGR14   Female   Neuromuscular   None                 10.9                             0                             Bilateral             5.5 mm, 90 mm   Hooks T3 to T5        Screws L2 to L3      
  MCGR15   Male     Congenital      VEPTR                9.7                              0                             Monolateral           4.5 mm, 70 mm   Hooks T3 to T5        Screws T12 to L1     Apical convex pedicle screw epiphyseodesis and convex side trolley construct
  MCGR16   Female   Congenital      VEPTR                7.6                              0                             Monolateral           4.5 mm, 90 mm   Hooks T2 to T3        Screws L1 to L2      Apical convex pedicle screw epiphyseodesis
  MCGR17   Female   Neuromuscular   Brace                5.3                              0                             Bilateral             4.5 mm, 90 mm   Hooks T1 to T5        Screws L4 to ilium   
  MCGR18   Female   Congenital      None                 9.1                              0                             Bilateral             5.5 mm, 90 mm   Hooks T2 to T4        Screws L2 to L3      Apical convex pedicle screw epiphyseodesis
  MCGR19   Female   Idiopathic      Brace                12.0                             0                             Bilateral             5.5 mm, 90 mm   Hooks T3 to T5        Screws L2 to L3      
  MCGR20   Female   Syndromic       Cast                 1.8                              0                             Bilateral             4.5 mm, 70 mm   Hooks T3 to T5        Screws L2 to L3      
  MCGR21   Female   Congenital      Brace                11.9                             0                             Bilateral             5.5 mm, 90 mm   Hooks T3 to T5        Screws L1 to L2      
  MCGR22   Female   Idiopathic      Brace                14.9                             II                            Bilateral             5.5 mm, 90 mm   Hooks T2 to T4        Screws T12 to L1     
  MCGR23   Male     Congenital      Brace                18.4                             IV                            Bilateral             5.5 mm, 90 mm   Hooks T3 to T4        Screws L3 to L4      Apical convex pedicle screw epiphyseodesis
  MCGR24   Male     Congenital      None                 14.2                             0                             Bilateral             5.5 mm, 90 mm   Hooks T1 to T3        Screws T12 to L1     
  MCGR25   Male     Neuromuscular   None                 12.0                             0                             Bilateral             4.5 mm, 70 mm   Hooks T1 to T2        Screws T10 to T12    
  MCGR26   Male     Neuromuscular   tGR                  9.2                              0                             Bilateral             4.5 mm, 90 mm   Hooks T2 to T3        Screws T11 to T12    
  MCGR27   Female   Neuromuscular   None                 10.3                             0                             Bilateral             4.5 mm, 90 mm   Hooks T2 to T5        Screws L4 to ilium   
  MCGR28   Female   Neuromuscular   None                 3.5                              0                             Bilateral             5.5 mm, 70 mm   Hooks T1 to T4        Screws T12 to L1     
  MCGR29   Female   Idiopathic      Brace                6.5                              0                             Bilateral             5.5 mm, 90 mm   Hooks T3 to T5        Screws L1 to L2      
  MCGR30   Female   Syndromic       None                 6.8                              0                             Bilateral             5.5 mm, 90 mm   Hooks T2 to T3        Screws T12 to L1     

C-EOS, classification of early onset scoliosis; VEPTR, vertical expandable titanium rib prosthesis

In all, 25/30 (83%) suffered from non-idiopathic EOS (11 congenital, ten neuromuscular, four syndromic) and only five patients were treated for idiopathic EOS. In 13 patients either serial casting or brace treatment was applied prior to MCGR insertion. Nine patients had previous treatment with non-motorized distraction-based implants. Eight of them underwent conversion from vertical expandable titanium rib prosthesis (VEPTR) and one patient had his traditional growing rods (tGR) exchanged for MCGR. Eight patients did not have specific treatment before getting MCGR.

Mean follow-up time of all patients was 25 months ([sd]{.smallcaps} 10; 6 to 42). In all, 18 patients had a minimum follow-up of two years after MCGR insertion. Eight of these 18 patients had conversion from non-motorized implants (all VEPTR). Two of these 18 patients had graduated from growth-sparing treatment and underwent final fusion surgery. One of them with conversion from VEPTR to MCGR had a staged procedure with removal of MCGR and 21 days of inpatient halo-gravity traction followed by posterior instrumented spinal fusion (PISF). The other patient underwent one-time MCGR removal and PISF.

Deformity evolution was analyzed for patients with a minimum follow-up of two years (18/30) after MCGR insertion ([Fig. 1](#Fig1){ref-type="fig"}). Mean major curve Cobb angle before MCGR insertion was 66° ([sd]{.smallcaps} 19°; 35° to 106°), changing to 47° ([sd]{.smallcaps} 13°; 29° to 79°) after MCGR implantation (29% correction rate; p \< 0.001). Mean main kyphosis angle changed from 52° ([sd]{.smallcaps} 31°; 9° to 146°) before to 42° ([sd]{.smallcaps} 25°; 8° to 119°) after MCGR implantation (19% correction rate; p = 0.023). Mean major curve before MCGR and curve correction with MCGR insertion was less in patients with previous growth-sparing surgical treatment (58°; 14%) compared with patients without previous spine surgery (72°; 38%). On the other hand, mean main kyphosis before MCGR was higher in patients who underwent conversion from non-motorized implants (63° *versus* 43°). After a minimum follow-up period of two years both, patients with and without previous growth-sparing surgery, showed a steady increase in main kyphosis with subsequent lengthenings. Patients after conversion from non-motorized spinal implants even showed a loss of major curve correction, reaching the levels before MCGR insertion.

![Changes in major curve (**a**) and main kyphosis (**b**) before and after implantation of magnetically controlled growing rods (MCGR), and at latest follow-up (^[@CR1]^only patients with a minimum follow-up period of two years are included) for all patients (continuous line), for patients with previous growth-sparing surgical treatment (dashed line) and for patients without previous growth-sparing surgical treatment (dotted line).](jco-13-196-g0001){#Fig1}

There was a relevant increase in both T1 to T12 (+ 1.8 cm; [sd]{.smallcaps} 1.1; p \< 0.001) and T1 to S1 (+ 2.7 cm; [sd]{.smallcaps} 1.6; p \< 0.001) distance with MCGR implantation. Like the changes in major curve Cobb angle, the increase in T1 to T12 and T1 to S1 length for patients converted from non-motorized implants was less (+ 0.6 cm for T1 to T12 and + 1.3 cm for T1 to S1) compared with patients without previous spine surgery (+ 2.2 cm for T1 to T12 and + 3.3 cm for T1 to S1). Due to the heterogeneity of the cohort in terms of age, aetiology and extent of the deformity, as well as the length of the instrumented part of the spine, we focused on the changes in T1 to S1 distance during treatment. Interestingly, there was a slight loss of T1 to S1 distance in the interval between MCGR implantation and the first lengthening. In the further course of the treatment there was a steady increase of the T1 to S1 distance, however, with a smaller gain in length over time ([Fig. 2](#Fig2){ref-type="fig"}).

![Normalized changes in T1 to S1 distance during treatment with magnetically controlled growing rods in patients with a minimum follow-up period of two years (red = all patients (n = 18); green = patients with previous growth-sparing surgical treatment (n = 8); blue = patients without previous growth-sparing surgical treatment (n = 10)).](jco-13-196-g0002){#Fig2}

In all, 23 patients had bilateral MCGR implantation. Six of the seven patients with unilateral MCGR insertion had previous unilateral VEPTR treatment. In one female patient with neuromuscular scoliosis due to a myopathy, only one concave-sided rod could be inserted, considering the extent of curvature (Cobb angle of 83°) and the limited soft-tissue coverage at a body weight of just under 12 kg. Apart from one case, all patients without previous growth-sparing surgery had a hybrid instrumentation consisting of hooks for the proximal and pedicle screws for the distal foundation. In patients pre-operated with VEPTR, the cranial fixation was mostly performed using the *in situ* VEPTR rib hooks. Changes to pedicle hooks were performed in two cases. In the caudal region, the original VEPTR fixation was used in all pre-operated patients. When implanting the MCGR, we tried to use the longer actuator (90 mm) and a 5.5-mm rod whenever possible. Depending on the anatomical conditions and the deformity, we used a special fixation technique in some of the cases. In order to be able to use the 5.5-mm MAGEC rods even in small children with limited bony anatomy, 4.5-mm anchor points were used, which were connected to a 5.5-mm rod via side-to-side connectors ([Fig. 3](#Fig3){ref-type="fig"}). This has enabled the use of the 5.5-mm/90-mm actuator MAGEC in 76% (16/21) of the patients without previous spine surgery.

![Radiographs of a six-year-old girl with an idiopathic early onset scoliosis before (**a**) and after (**b**) insertion of magnetically controlled growing rods (MCGR). A 4.5-mm system was used for the proximal and distal foundations and the foundations were linked to the 5.5-mm MCGRs by 4.5-/5.5-mm side-by-side rod connectors (**c**) enabling the use of two 90-mm actuator MCGRs.](jco-13-196-g0003){#Fig3}

So far, a total of 249 elective outpatient implant lengthenings have been performed. Considering a six-month interval for surgical extension of non-motorized implants, the use of MCGR enabled the avoidance of 116 elective inpatient surgical extensions under general anaesthesia. There were 12 documented complications in 11/30 (37%) patients leading to a total of 13 unplanned returns to the OR ([Table 2](#Tab2){ref-type="table"}). In all, 4/9 (44%) of patients after conversion from VEPTR or tGR treatment and 7/21 (33%) of patients without previous growth-sparing surgery were affected. Two complications were rated as severity grade I,^[@CR16]^ not requiring unplanned surgery. In one case, delayed wound healing occurred after the index surgery. In the second patient, both rods failed, leading to premature indication for definitive spondylodesis. During the definitive spondylodesis, after removal of the MCGR, a pronounced metallosis at the level of the actuator could be observed ([Fig. 4](#Fig4){ref-type="fig"}). Seven complications were rated as severity grad IIA, requiring one additional surgery. In one girl with an idiopathic EOS one of the MAGEC rods had to be exchanged due to rod malfunction. Four of the patients with previous VEPTR treatment sustained failure of proximal (three times) or distal (one time) implant fixation. Two other patients required extension/refixation of the proximal foundation due to proximal junctional kyphosis (PJK). One of these patients with a neuromuscular scoliosis due to a central core myopathy had an additional operation with fixation up to the occiput. A further two complications were rated as severity grad IIB. Both patients sustained a deep surgical site infection (SSI) after the index operation. In both cases, a cerebrospinal fluid leak could be objectified during the revision operation and three, respectively two, unplanned operations were necessary.

###### 

Complications after implantation of magnetically controlled growing rods (MCGR)

  ID       Gender   C-EOS           Previous treatment   Complication(s)                   Mono/bilateral MCGR   Severity score[\*](#TFN2_1){ref-type="table-fn"}   Delay until complication(s)[†](#TFN2_2){ref-type="table-fn"}   Treatment
  -------- -------- --------------- -------------------- --------------------------------- --------------------- -------------------------------------------------- -------------------------------------------------------------- --------------------------------------------------------------------------------------------------
  MCGR02   Male     Syndromic       Cast                 Delayed wound healing             Bilateral             I                                                  0                                                              None
  MCGR04   Female   Syndromic       VEPTR                Dislocation of VEPTR ala hook     Bilateral             IIA                                                11                                                             Refixation of ala hook
  MCGR05   Male     Congenital      VEPTR                Dislocation of VEPTR rib cradle   Monolateral           IIA                                                7                                                              Refixation of rib cradle
  MCGR06   Female   Idiopathic      Brace                MAGEC rod failure right side      Bilateral             IIA                                                10                                                             Change of MAGEC rod
  MCGR07   Female   Idiopathic      Brace                MAGEC rod failure bilateral       Bilateral             I                                                  17                                                             Premature indication for definitive spondylodesis
  MCGR08   Male     Congenital      VEPTR                Dislocation of VEPTR rib cradle   Bilateral             IIA                                                21                                                             Refixation of VEPTR rib cradle
  MCGR12   Male     Congenital      VEPTR                Dislocation of VEPTR rib cradle   Monolateral           IIA                                                1                                                              Refixation of VEPTR rib cradle
  MCGR17   Female   Neuromuscular   Brace                2 × PJK                           Bilateral             IIA                                                1\. 10 2. 17                                                   1\. Proximal extension of the instrumentation 2. Extension of the instrumentation to the occiput
  MCGR21   Female   Congenital      Brace                PJK                               Bilateral             IIA                                                10                                                             Proximal extension of the instrumentation
  MCGR28   Female   Neuromuscular   None                 SSI                               Bilateral             IIB                                                0                                                              3 × wound revision including insertion of a liquor drainage
  MCGR29   Female   Idiopathic      Brace                SSI                               Bilateral             IIB                                                0                                                              2 × wound revision including insertion of a liquor drainage

complication severity score according to Smith et al(16)

months after index surgery

C-EOS, classification of early onset scoliosis; PJK, proximal junctional kyphosis; SSI, surgical site infection; VEPTR, vertical expandable titanium rib prosthesis

![(**a**) Shows clear material abrasion in the telescoping part of the explanted magnetically controlled growing rod (MCGR) in a female patient with idiopathic early onset scoliosis; (**b**) illustrates the pronounced metallosis present in the excised soft tissues surrounding the telescoping portion of the MCGR.](jco-13-196-g0004){#Fig4}

Discussion {#Sec4}
==========

The availability of motorized implants for the therapeutic management of EOS and the abandonment of regular surgical device lengthening has led to a significant improvement in health-related quality of life of affected patients.^[@CR18]^ In addition, there is a potential for cost savings due to the reduced number of inpatient stays and operations under general anaesthesia.^[@CR19]-[@CR21]^ These developments are of particular benefit for our young patients, but, nevertheless, a reflective approach to indicate the use of MCGR is still required.

Although more than 100 elective implant lengthening surgeries could be avoided in our cohort by using MCGR, the complication rate (37%) and the rate of unplanned returns to the OR (30%) are not insignificant. This has also been confirmed by other authors. Thakar et al^[@CR12]^ just recently presented a systematic review on the complication profile of MCGR in EOS. They included 15 publications including 336 patients with an average follow-up of 30 months. Although studies reporting on the use of MCGR as part of a hybrid growing system were excluded, the reported mean complication rate (45%) and the rate of unplanned revision surgery (33%) were very similar to our results. And, as with our patients, most of the complications were implant-related. Like them, we could not show a significant difference between primary and conversion procedures, although, in our series the complication rate in patients converted from non-motorized implants was 44% compared with 33% in patients without previous surgical treatment. The overall rate of deep SSIs appears to be less when using MCGR compared with non-motorized distraction-based systems. In a large series of 379 tGR patients, Kabirian et al^[@CR22]^ found a rate of 11.1% of SSI requiring unplanned surgery and a study on our own VEPTR patients showed a 21.7% (5/23) rate of SSI^[@CR23]^. Thakar et al^[@CR12]^ in their review on patients treated with MCGR reported only 3.3% deep SSI with two SSIs in 30 patients; our SSI rate is 6.7%. This is likely due to the reduced number of elective surgeries for implant lengthening. At least, we have shown that bacterial implant colonization is detectable in 48% of VEPTR patients undergoing repetitive surgical lengthening.^[@CR24]^

Our PJK rate of 6.7% (2/30) is higher compared with those reported by Thakar et al^[@CR12]^ (3.8%) and Bess et al^[@CR25]^ (2.1%). Another study, however, reported on significantly higher rates of PJK of up to 28%.^[@CR26]^ The known risk factors to develop PJK, namely preoperative thoracic hyperkyphosis and increased pelvic incidence,^[@CR26]^ were met in our two patients with PJK.

The marked deformity correction with the index surgery, especially in patients without conversion procedures, has already been described for tGR and other non-motorized implants. And, it would be surprising if different results were obtained with the use of MCGR, given the same spectrum of indications and using an equal operation technique. The extent to which this also applies to the law of diminishing returns described by Sankar et al^[@CR27]^ has not yet been conclusively clarified. Whether or not shorter intervals between scheduled implant lengthening proceeded with the use of MCGR lead to greater gain in spinal length and help to avoid spontaneous autofusion of the affected segments of the spine is debated. The fact that with an increasing number of extensions, the ultrasound-controlled gain in rod length decreases in our patients ([Fig. 5](#Fig5){ref-type="fig"}) is in line with the statement of Ahmad et al^[@CR28]^ who reported on a rather gradual linear decline in lengthening when using MCGR compared with a rapid initial decline in tGR treatment, and Prof. Kenneth Cheung recently called it "the law of diminished gain in length" at the 2018 International Congress on Early Onset Scoliosis (ICEOS) meeting in Lisbon.

![Progression of implant length measured with ultrasound dependent on the number of elongations.](jco-13-196-g0005){#Fig5}

Also uncertain are the effects of the sometimes pronounced peri-implant metallosis and the associated release of metal ions into the surrounding soft tissues and into the bloodstream.^[@CR13]^ We have also found an obvious metallosis at the time of elective or unplanned rod exchanges most of the time, especially in the area of the telescoping part of the rod. However, the most pronounced finding was in a patient with an idiopathic EOS who underwent premature definitive instrumented fusion due to bilateral rod failure ([Fig. 4](#Fig4){ref-type="fig"}). The extent to which rod failure and the presence of metallosis are related is not yet known. Several publications by different authors have drawn attention to this problem and, in addition to the recommendation to meticulously monitor individual patients, the demand has been made for an international register of patients with MCGR.^[@CR13],[@CR29]-[@CR31]^

So far, two of our MAGEC patients had a definitive instrumented fusion. One of them was previously treated with bilateral VEPTR, including a fixation to the pelvis. With final fusion surgery the rigidity of the autofused spine and thorax did not allow relevant deformity correction, even with preoperative halo-gravity traction. In the second patient with an idiopathic EOS, the fusion was performed early due to bilateral rod failure. With Risser stage III and an age of 14.8 years, we, as well as the patient and her parents, did not wish to continue with growth-sparing treatment. With final spondylodesis, the Cobb angle of the major curve was corrected from 46° to 35° without extending the instrumented levels.

Recently, several studies have been published on so-called graduates from growth-sparing surgical techniques,^[@CR32]-[@CR35]^ and Cheung et al^[@CR10]^ gave a glimpse of five MCGR graduates in their mean six-year follow-up report on MCGR patients. Not surprisingly, the prerequisites and decision-making processes for the choice of definitive treatment at skeletal maturity seem to correspond to those of non-motorized distraction-based systems. Foundations are fused, and the part of the spine bridged by the implants is not necessarily fused, but functionally stiff.

Conclusion {#Sec5}
==========

The use of motorized implants has clearly improved the quality of life of EOS patients. Nevertheless, we must be aware of a considerable complication and re-operation rate and that we are still a long way from reaching our goal of non-fusion surgical management of EOS. The spectrum of indications and the surgical technique still largely correspond to those of non-motorized distraction-based systems. Accordingly, we will be confronted with the same difficulties and challenges in the decision-making process when shaping the final treatment strategy at the end of growth. Uniform protocols regarding extension intervals and extent of the desired lengthening are missing as well as aetiology-dependent treatment algorithms. In addition, there are implant-associated factors, like metallosis and reduced gain in length over time, the consequences of which we do not yet have a clear understanding of. Propagated patient and treatment registries should be implemented, as should the proposal for a prospective randomized controlled trial,^[@CR36]^ to clarify these open questions and provide optimal protection for our patients.
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